boranes has been researched along with Osteoporosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Endo, Y; Hirata, M; Inada, M; Matsumoto, C; Miyaura, C; Murphy, G; Nagase, H; Tominari, T; Watanabe, K | 1 |
| Burnham, BS | 1 |
| Chen, SY; Hall, IH; Rajendran, KG; Sood, A; Spielvogel, BF | 1 |
1 review(s) available for boranes and Osteoporosis
| Article | Year |
|---|---|
Synthesis and pharmacological activities of amine-boranes.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Antiviral Agents; Boranes; Dopamine Antagonists; Humans; Hypolipidemic Agents; Molecular Structure; Osteoporosis; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y1; Time Factors | 2005 |
2 other study(ies) available for boranes and Osteoporosis
| Article | Year |
|---|---|
BA321, a novel carborane analog that binds to androgen and estrogen receptors, acts as a new selective androgen receptor modulator of bone in male mice.
Topics: Androgens; Animals; Bone and Bones; Boranes; Dose-Response Relationship, Drug; Female; Gonads; Humans; Male; Mice; Mice, Inbred Strains; Orchiectomy; Osteoporosis; Ovariectomy; Receptors, Androgen; Receptors, Estrogen; Treatment Outcome | 2016 |
The anti-osteoporotic activity of amine-carboxyboranes in rodents.
Topics: Animals; Bone Neoplasms; Boranes; Calcium; Female; Hydroxyproline; In Vitro Techniques; Male; Mice; Osteoporosis; Osteosarcoma; Phosphorus; Rats; Rats, Sprague-Dawley; Skull; Tumor Cells, Cultured | 1995 |